Zentek Ltd. (ZTEK)
USD 1.78
(1.72%)
USD 1.78
(1.72%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | -301.26 Thousand CAD | -20.7% |
| 2022 | 14.72 Million CAD | 19.52% |
| 2021 | 12.32 Million CAD | 209.18% |
| 2020 | 3.98 Million CAD | 151.1% |
| 2019 | 1.58 Million CAD | -35.71% |
| 2018 | 2.46 Million CAD | 50.53% |
| 2017 | 1.63 Million CAD | -42.38% |
| 2016 | 2.84 Million CAD | -32.26% |
| 2015 | 4.2 Million CAD | 37.48% |
| 2014 | 3.05 Million CAD | -14.21% |
| 2013 | 3.56 Million CAD | 31.43% |
| 2012 | 2.71 Million CAD | 58.17% |
| 2011 | 1.71 Million CAD | 10.88% |
| 2010 | 1.54 Million CAD | 906.65% |
| 2009 | 153.53 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 823.83 Thousand CAD | -1.54% |
| 2023 Q1 | 5.08 Million CAD | 73.96% |
| 2023 FY | 11.67 Million CAD | -20.7% |
| 2023 Q4 | 2.34 Million CAD | -16.59% |
| 2023 Q3 | 2.81 Million CAD | -16.57% |
| 2023 Q2 | 3.37 Million CAD | -33.71% |
| 2022 Q3 | 3.36 Million CAD | 0.6% |
| 2022 Q4 | 2.92 Million CAD | -13.2% |
| 2022 FY | 14.72 Million CAD | 19.52% |
| 2022 Q1 | 5.08 Million CAD | 12.76% |
| 2022 Q2 | 3.34 Million CAD | -34.16% |
| 2021 Q3 | 2.47 Million CAD | -20.3% |
| 2021 Q4 | 4.51 Million CAD | 82.44% |
| 2021 Q2 | 3.1 Million CAD | 65.85% |
| 2021 Q1 | 1.87 Million CAD | 50.37% |
| 2021 FY | 12.32 Million CAD | 209.18% |
| 2020 Q1 | 387.04 Thousand CAD | -42.93% |
| 2020 FY | 3.98 Million CAD | 151.1% |
| 2020 Q2 | 453.85 Thousand CAD | 17.26% |
| 2020 Q3 | 1.9 Million CAD | 318.66% |
| 2020 Q4 | 1.24 Million CAD | -34.54% |
| 2019 Q4 | 678.21 Thousand CAD | 328.05% |
| 2019 Q3 | 158.44 Thousand CAD | -57.02% |
| 2019 Q1 | 381.69 Thousand CAD | -37.91% |
| 2019 Q2 | 368.62 Thousand CAD | -3.42% |
| 2019 FY | 1.58 Million CAD | -35.71% |
| 2018 Q2 | 1.01 Million CAD | 292.78% |
| 2018 Q3 | 582.08 Thousand CAD | -42.63% |
| 2018 Q4 | 614.72 Thousand CAD | 5.61% |
| 2018 FY | 2.46 Million CAD | 50.53% |
| 2018 Q1 | 258.3 Thousand CAD | -45.35% |
| 2017 Q3 | 321.43 Thousand CAD | 6.28% |
| 2017 FY | 1.63 Million CAD | -42.38% |
| 2017 Q4 | 472.63 Thousand CAD | 47.04% |
| 2017 Q2 | 302.45 Thousand CAD | -44.33% |
| 2017 Q1 | 543.31 Thousand CAD | -16.35% |
| 2016 Q2 | 1.02 Million CAD | 158.61% |
| 2016 Q3 | 775.77 Thousand CAD | -24.29% |
| 2016 Q1 | 396.2 Thousand CAD | -44.61% |
| 2016 Q4 | 649.52 Thousand CAD | -16.27% |
| 2016 FY | 2.84 Million CAD | -32.26% |
| 2015 Q3 | 834.75 Thousand CAD | -37.7% |
| 2015 Q4 | 715.27 Thousand CAD | -14.31% |
| 2015 Q1 | 1.31 Million CAD | 119.92% |
| 2015 Q2 | 1.33 Million CAD | 2.12% |
| 2015 FY | 4.2 Million CAD | 37.48% |
| 2014 Q2 | 1.05 Million CAD | 60.53% |
| 2014 FY | 3.05 Million CAD | -14.21% |
| 2014 Q3 | 748.6 Thousand CAD | -29.0% |
| 2014 Q4 | 596.59 Thousand CAD | -20.31% |
| 2014 Q1 | 656.81 Thousand CAD | -7.5% |
| 2013 FY | 3.56 Million CAD | 31.43% |
| 2013 Q1 | 852.24 Thousand CAD | -41.36% |
| 2013 Q2 | 900.62 Thousand CAD | 5.68% |
| 2013 Q3 | 1.09 Million CAD | 22.11% |
| 2013 Q4 | 710.06 Thousand CAD | -35.43% |
| 2012 Q1 | 402.6 Thousand CAD | 24.7% |
| 2012 Q2 | 296.72 Thousand CAD | -26.3% |
| 2012 Q3 | 558 Thousand CAD | 88.06% |
| 2012 Q4 | 1.45 Million CAD | 160.46% |
| 2012 FY | 2.71 Million CAD | 58.17% |
| 2011 Q1 | 500.12 Thousand CAD | 7.41% |
| 2011 Q2 | 519.25 Thousand CAD | 3.82% |
| 2011 Q3 | 371.56 Thousand CAD | -28.44% |
| 2011 Q4 | 322.85 Thousand CAD | -13.11% |
| 2011 FY | 1.71 Million CAD | 10.88% |
| 2010 FY | 1.54 Million CAD | 906.65% |
| 2010 Q3 | 656.16 Thousand CAD | 164.75% |
| 2010 Q1 | 175.94 Thousand CAD | 14.6% |
| 2010 Q2 | 247.84 Thousand CAD | 40.86% |
| 2010 Q4 | 465.61 Thousand CAD | -29.04% |
| 2009 Q4 | 153.53 Thousand CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 FY | 153.53 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 100.289% |
| AngioDynamics, Inc. | 252.41 Million USD | 100.119% |
| AtriCure, Inc. | 327.05 Million USD | 100.092% |
| Avinger, Inc. | 18.63 Million USD | 101.616% |
| Azenta, Inc. | 336.26 Million USD | 100.09% |
| BioLife Solutions, Inc. | 117.57 Million USD | 100.256% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 100.017% |
| Daxor Corporation | 1.28 Million USD | 123.527% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 101.245% |
| Femasys Inc. | 15.2 Million USD | 101.982% |
| GlucoTrack, Inc. | 7.1 Million USD | 104.241% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 100.514% |
| Hologic, Inc. | 1.34 Billion USD | 100.022% |
| ICU Medical, Inc. | 717.04 Million USD | 100.042% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 100.01% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 101.154% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 100.333% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | -152.465% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | -152.465% |
| Masimo Corporation | 867 Million USD | 100.035% |
| Microbot Medical Inc. | 9.85 Million USD | 103.057% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | 101.636% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 100.066% |
| Nephros, Inc. | 9.78 Million USD | 103.079% |
| NovoCure Limited | 613.92 Million USD | 100.049% |
| NEXGEL, Inc. | 4.09 Million USD | 107.355% |
| NEXGEL, Inc. | 4.09 Million USD | 107.355% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 100.295% |
| OraSure Technologies, Inc. | 125.34 Million USD | 100.24% |
| Pro-Dex, Inc. | 7.37 Million USD | 104.083% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 100.691% |
| Predictive Oncology Inc. | 15.22 Million USD | 101.978% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | 103.535% |
| QuidelOrtho Corporation | 1.35 Billion USD | 100.022% |
| Repligen Corporation | 261.12 Million USD | 100.115% |
| Sanara MedTech Inc. | 61.12 Million USD | 100.493% |
| STAAR Surgical Company | 224.55 Million USD | 100.134% |
| Sharps Technology, Inc. | 10.12 Million USD | 102.975% |
| Utah Medical Products, Inc. | 13.26 Million USD | 102.272% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 100.017% |
| Jin Medical International Ltd. | 3.91 Million USD | 107.69% |